Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CCRL1 Antikörper

Der Maus Monoklonal Anti-CCRL1-Antikörper wurde für ELISA, IHC und ICFC validiert. Er ist geeignet, CCRL1 in Proben von Human zu detektieren.
Produktnummer ABIN2664103

Kurzübersicht für CCRL1 Antikörper (ABIN2664103)

Target

Alle CCRL1 Antikörper anzeigen
CCRL1 (Chemokine (C-C Motif) Receptor-Like 1 (CCRL1))

Reaktivität

  • 19
  • 10
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 16
  • 2
  • 1
Maus

Klonalität

  • 18
  • 1
Monoklonal

Konjugat

  • 18
  • 1
Dieser CCRL1 Antikörper ist unkonjugiert

Applikation

  • 14
  • 10
  • 8
  • 5
  • 4
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC), Intracellular Flow Cytometry (ICFC)

Klon

13E11
  • Aufreinigung

    The antibody was purified by affinity chromatography.

    Isotyp

    IgG2b kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.5 mg/mL

    Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Target

    CCRL1 (Chemokine (C-C Motif) Receptor-Like 1 (CCRL1))

    Andere Bezeichnung

    CCX-CKR

    Hintergrund

    Human CCX-CKR, also known as CCRL1, is a 40 kD, G-protein-coupled, seven transmembrane receptor. CCRL1 is a decoy receptor for CCL2, CCL8, CCL13, CCL19, CCL21 and CCL25 that regulates chemotaxis of lymphocytes and cancer cells. Chemokine binding by CCX-CKR causes its internalization, reducing levels of available chemokine, and thus regulating migration of lymphocytes and cancerous cells. CCX-CKR is expressed by stromal cells of skin-draining lymph nodes, thymic epithelial cells, and immature dendritic cells (DCs). A low CCX-CKR expression in tumor cells correlates with a poor survival rate of breast cancer patients.
Sie sind hier:
Chat with us!